Multicenter, Safety Study Of Maraviroc

NCT00478231 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
HIV Infection

Interventions

DRUG: Maraviroc

Sponsor

ViiV Healthcare

Collaborators

[object Object]